Status:

ACTIVE_NOT_RECRUITING

Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Collaborating Sponsors:

University Hospital Freiburg

Conditions:

Surgical Site Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Surgical site infections (SSI) after spine surgery may occur in up to 12% of cases and can lead to increased morbidity, and healthcare costs In this randomized controlled trial the investigators aim t...

Detailed Description

Background: Surgical site infections (SSI) after spine surgery may occur in up to 12% of cases and can lead to increased morbidity, and healthcare costs. Numerous retrospective studies suggest the us...

Eligibility Criteria

Inclusion

  • Patients ≥ 18 years of age requiring open instrumented dorsal spinal fusion of at least 1 level (involving two adjacent vertebras and one intervertebral disc)
  • Signed informed consent

Exclusion

  • Preoperative ongoing infectious disease present as judged by primary surgeon (based on lab results and clinical assessment);
  • Previous spine surgery at index level within last 90 days;
  • Known allergy to vancomycin;
  • Percutaneous or transmuscular instrumentation (minimally-invasive surgery) only without lumbar interbody fusion;
  • Postoperative radiotherapy of surgical site required (e.g. for tumor)
  • Preexisting cochlea damage OR known history of hearing loss NOT clearly associated with age-related hearing impairment (presbycusis);
  • Renal insufficiency with stage 4 chronic kidney disease (CKD) with a glomerular filtration rate (GFR) of 15-30 ml/min or worse;
  • Pregnancy or breastfeeding women;
  • Participation in other ongoing clinical trials;
  • Patients lacking capacity to consent;

Key Trial Info

Start Date :

October 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2027

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT04017468

Start Date

October 15 2019

End Date

March 31 2027

Last Update

July 9 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Kantonsspital St. Gallen

Sankt Gallen, Canton of St. Gallen, Switzerland, 9007

2

University Hostpital Bern, Department of Neurosurgery

Bern, Switzerland, 3010

3

University Hostpital Bern, Department of orthopaedy

Bern, Switzerland, 3010

4

Lindenhofspital Bern

Bern, Switzerland, 3012